TORL BioTherapeutics
Drug DiscoveryWebsite
Developer of a drug development company designed to focus on antibody-drug conjugates (ADCs) and other biologics. The company leverages target identification and early discovery work before electing t...
Valuation
$0
Share Price
N/A
Total Raised
$454.3M
Last Round
Later Stage VC (Series B2)
Apr 2024
Latest Funding Round
Later Stage VC (Series B2)
Apr 10, 2024
$158.3M
raised
Investors
+18 other investors